The fast pace of technological development can make it difficult to understand how AI could be applied and what its benefits ...

Leading oncologists said AI will one day be as integrated into cancer care as it is in smartphones and self-driving cars. #STATBreakthrough ...

News broke yesterday that researchers in Philadelphia appear to have successfully treated a 6-month-old baby boy, called KJ, ...

The study finds that AI alone won’t solve clinical trial complexities — trained, cross-functional teams are still the key to ...

If mishandled, this move could undermine public trust in the FDA and squander a once-in-a-generation opportunity to lead the ...

MadeAi—its award-winning generative AI-based platform that expedites the synthesis of content and data for the life sciences, helping time-strapped teams to scale faster, strengthen regulatory ...

Harvard Business Review announced its latest top 10 uses of generative AI. At No. 1 is therapy/companionship. Here's an AI ...

Corporate R&D event highlighted positive ACR-368 data in endometrial cancer patients who had all received prior anti-PD-1 and platinum-based chemotherapy Confirmed overall response rate (cORR) of 35% ...

The study demonstrates how generative deep learning, when combined with structural prediction and affinity modeling, can ...

Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...

Confirmed overall response rate (cORR) of 35% and median duration of response (mDOR) >5.6 months (not yet reached) observed in OncoSignature-positive (BM+) patients, a majority of whom were refractory ...

CapeStart debuted a major new release of MadeAi™, its GenAI platform that expedites the synthesis of content and data for the life sciences.